Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AGfiledCriticalBayer Pharma AG
Priority to HN2002000092ApriorityCriticalpatent/HN2002000092A/en
Publication of HN2002000092ApublicationCriticalpatent/HN2002000092A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVOS COMPUESTOS, A PROCEDIMIENTOS PARA SU PROPARACIÓN Y A SU USO COMO MEDICAMENTOS, ESPECIALMENTE COMO AGENTES ANTIVIRALES, ESPECIALMENTE FRENTE A CITOMEGALOVIRUS.THE PRESENT INVENTION REFERS TO NEW COMPOUNDS, TO PROCEDURES FOR THEIR PROPARATION AND TO THEIR USE AS MEDICINES, ESPECIALLY AS ANTIVIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALOVIRUSES.
HN2002000092A2002-04-172002-04-17
NEW ARILSUFONAMIDAS AS ANTIVIRAL AGENTS.
HN2002000092A
(en)